Combining an alarmin HMGN1 peptide with PD-L1 blockade facilitates stem-like CD8+ T cell expansion and results in robust antitumor effects
暂无分享,去创建一个
K. Matsushima | S. Ueha | S. Shichino | J. Oppenheim | H. Ogiwara | De Yang | Shiro Shibayama | S. Yokochi | Y. Ishiwata | S. Deshimaru | Chang-Yu Chen | Tatsuro Ogawa | Yuzuka Kanno
[1] A. Regev,et al. Abstract PR01: A cancer cell program promotes T-cell exclusion and resistance to checkpoint blockade , 2020, Cancer Research.
[2] Q. Guan,et al. Mechanisms of resistance to immune checkpoint inhibitors , 2020, World Chinese Journal of Digestology.
[3] M. Merad,et al. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer , 2020, Nature Cancer.
[4] E. Kenigsberg,et al. A conserved dendritic-cell regulatory program limits antitumour immunity , 2020, Nature.
[5] Mirjana Efremova,et al. CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes , 2020, Nature Protocols.
[6] A. Kamphorst,et al. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells , 2019, Nature.
[7] A. Kallies,et al. Precursor exhausted T cells: key to successful immunotherapy? , 2019, Nature Reviews Immunology.
[8] J. Locasale,et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism , 2019, Science.
[9] F. Hodi,et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2019, Nature Immunology.
[10] K. Matsushima,et al. Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice , 2019, Journal of Immunotherapy for Cancer.
[11] K. Matsushima,et al. Transcriptome network analysis identifies protective role of the LXR/SREBP-1c axis in murine pulmonary fibrosis. , 2019, JCI insight.
[12] Daniel E. Speiser,et al. Intratumoral Tcf1+PD‐1+CD8+ T Cells with Stem‐like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy , 2019, Immunity.
[13] Ralph Weissleder,et al. Successful Anti‐PD‐1 Cancer Immunotherapy Requires T Cell‐Dendritic Cell Crosstalk Involving the Cytokines IFN‐&ggr; and IL‐12 , 2018, Immunity.
[14] Paul J. Hoffman,et al. Comprehensive Integration of Single-Cell Data , 2018, Cell.
[15] Kerstin B. Meyer,et al. Single-cell reconstruction of the early maternal–fetal interface in humans , 2018, Nature.
[16] Russell J. Dickson,et al. CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory‐like Cells for Sustained Immunity , 2018, Immunity.
[17] R. Coffman,et al. SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study. , 2018, Cancer discovery.
[18] J. Oppenheim,et al. High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin. , 2018, Seminars in immunology.
[19] M. Fehlings,et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates , 2018, Nature.
[20] John C Marioni,et al. Detection and removal of barcode swapping in single-cell RNA-seq data , 2017, Nature Communications.
[21] Xin Chen,et al. Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Large Established Tumors , 2017, Scientific Reports.
[22] G. Sica,et al. Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent , 2017, Science.
[23] A. Elkahloun,et al. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness , 2016, Science Immunology.
[24] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[25] T. Kaisho,et al. Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma. , 2016, Cancer cell.
[26] Matheus C. Bürger,et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy , 2016, Nature.
[27] J. Oppenheim,et al. Alarmins and Antitumor Immunity. , 2016, Clinical therapeutics.
[28] F. Ginhoux,et al. Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition. , 2016, Immunity.
[29] Jedd D. Wolchok,et al. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations , 2016, Science Translational Medicine.
[30] M. Bustin,et al. Harnessing the alarmin HMGN1 for anticancer therapy. , 2015, Immunotherapy.
[31] Evan Z. Macosko,et al. Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.
[32] T. Schumacher,et al. Neoantigens in cancer immunotherapy , 2015, Science.
[33] K. Matsushima,et al. Robust Antitumor Effects of Combined Anti–CD4-Depleting Antibody and Anti–PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice , 2015, Cancer Immunology Research.
[34] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[35] M. Bustin,et al. The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant. , 2014, Cancer research.
[36] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[37] D. Barber,et al. Intravascular staining for discrimination of vascular and tissue leukocytes , 2014, Nature Protocols.
[38] Åsa K. Björklund,et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells , 2013, Nature Methods.
[39] Anushya Muruganujan,et al. Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.
[40] Burton E. Barnett,et al. Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection , 2012, Science.
[41] Gary D Bader,et al. A travel guide to Cytoscape plugins , 2012, Nature Methods.
[42] C. Drake,et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.
[43] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[44] M. Bustin,et al. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses , 2012, The Journal of experimental medicine.
[45] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[46] Jenna M. Sullivan,et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity , 2010, The Journal of experimental medicine.
[47] Pornpimol Charoentong,et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..
[48] M. Bustin,et al. HMG chromosomal proteins in development and disease. , 2007, Trends in cell biology.
[49] M. Bianchi,et al. HMG proteins: dynamic players in gene regulation and differentiation. , 2005, Current opinion in genetics & development.
[50] T. Blankenstein,et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. , 2004, Immunity.
[51] J. Cheville,et al. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. , 2003, Cancer research.
[52] Yoshimasa Tanaka,et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] M. Bustin. Chromatin unfolding and activation by HMGN(*) chromosomal proteins. , 2001, Trends in biochemical sciences.
[54] B. C. Gilbert,et al. Opportunities for intervention: discussing physical abuse during prenatal care visits. , 2000, American journal of preventive medicine.
[55] Simon C Watkins,et al. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. , 2000, Cancer research.
[56] Laurens van der Maaten,et al. Accelerating t-SNE using tree-based algorithms , 2014, J. Mach. Learn. Res..
[57] Geoffrey E. Hinton,et al. Visualizing Data using t-SNE , 2008 .